[Agranulocytosis and cholestatic hepatitis occurring during tetran therapy].
D000380:Agranulocytosis / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury; D002779:Cholestasis / Q000139:chemically induced*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation; D008875:Middle Aged; D010118:Oxytetracycline / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use
D011239:Prednisolone; D010118:Oxytetracycline
Tetran kezelés során fellépö agranulocytosis és cholostasisos hepatitis.